from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1396c/PE_PGRS25

LFCtreatmentdescriptionclass of inhibitor

-0.115

Amikacinug/mL Amikacintranslation

-0.962

Cap5-10ug/mL Capreomycintranslation

0.588

Rox10-50 ug/mL Roxithromycintranslation

-0.429

SM2-5 ug/mL Streptomycintranslation

0.885

Tet5-10 ug/mL Tetracyclinetranslation

-1.042

Rif0.2-5ug/mL Rifampicintranscription

-1.149

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.039

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.670

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.677

CPZ10-50 ug/mL Chlorpromazinerespiration

1.303

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.181

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.611

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.727

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.867

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.036

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.749

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.735

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.094

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.947

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.382

KCN5-20 ug/mL Potassium cyaniderespiration

-0.414

NaN30.2-2 mM Sodium aziderespiration

-0.014

Nigericin50 uM Nigericinrespiration

-0.477

TRC10-150 ug/mL Triclosanrespiration

-0.738

TRZ10-25 ug/mL Thioridazinerespiration

1.317

Valinomycin0.5-10 uM Valinomycinrespiration

-0.439

ZnSO42 mM ZnSO4respiration

-1.742

menadione6-10 ug/mL Menadionerespiration

1.135

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.371

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.018

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.011

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.241

NRP_1Non-replicating persistence stage 1dosRassociated

0.162

Amp0.2mg/mL AmpicillincellWall

0.370

Cephalexin20-100 ug/mL CephalexincellWall

-0.345

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.029

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.525

EMB10-20 ug/mL EthambutolcellWall

0.484

Eta12-40 ug/mL EthionamidecellWall

1.272

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.145

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.414

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.212

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.450

BZA0.12 mg/mL BenzamidearomaticAmides

-0.450

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.091

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.125

H2O24 mM hydrogen peroxideDNAdamaging

-1.026

Levo10 ug/mL LevofloxacinDNAdamaging

-0.060

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.836

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.438

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.586

UVUV-irradiationDNAdamaging

0.033

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.125

Antimycin12.5-50 ug/mL Antimycin A?

-0.630

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.325

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.007

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.524

PA8240.2-2 ug/mL PA-824?

0.331

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.176

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.574

Verapamil50 uM Verapamil?

-0.626

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.474

methoxatin10-20 ug/mL Methoxatin?